Has Cory Heal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $11,222 in general payments to Cory Heal, MD across 344 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cory Heal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cory Heal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cory Heal, MD

Radiation Oncology · Gilbert, AZNPI 1366970337

Payments from drug & device makers

$11,222in general payments, 2019–2025

Across 344 payments — averaging $32.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$1K
Novartis$873
Novocure Inc.$825
AstraZeneca$652
Pfizer$583
Johnson & Johnson$566
plus $6K from 54 others

What the payments were for

Travel & lodging$6786%
Food & beverage$10,46493%
Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	6	$1,179
Novartis	41	$873
Novocure Inc.	11	$825
AstraZeneca	24	$652
Pfizer	22	$583
Johnson & Johnson	24	$566
Daiichi Sankyo Inc.	20	$515
Progenics Pharmaceuticals, Inc.	13	$484
Tactile Systems Technology Inc	6	$433
Merck	19	$361
AbbVie	18	$354
Takeda Pharmaceuticals U.S.A., Inc.	10	$326
Visionrt, Inc.	2	$284
Sumitomo Pharma America, Inc.	11	$261
Seagen Inc.	6	$252
Bayer	12	$233
Springworks Therapeutics, Inc.	5	$200
Intuitive Surgical	3	$200
Eisai Inc.	8	$175
Telix Pharmaceuticals	2	$165
Gilead	2	$129
Servier Pharmaceuticals LLC	1	$123
Regeneron Healthcare Solutions, Inc.	4	$123
Medtronic	2	$115
Puma Biotechnology, Inc.	5	$113
Caris MPI, Inc.	1	$110
Beone Medicines USA, Inc.	4	$108
Boston Scientific	5	$92
IBA Proton Therapy, Inc.	1	$85
GE HealthCare	3	$81
Incyte Corporation	3	$76
ADC Therapeutics America, Inc.	3	$70
Sanofi	2	$57
Varian Medical Systems, Inc.	1	$54
Genmab U.S., Inc.	2	$52
E.r. Squibb & Sons, L.L.C.	3	$51
Ipsen Biopharmaceuticals, Inc	2	$50
GSK	2	$48
Boehringer Ingelheim	2	$47
AVEO Pharmaceuticals, Inc.	3	$46
Bristol Myers Squibb	2	$44
Pharmacosmos Therapeutics Inc.	2	$42
Bioprotect Medical, Inc.	2	$41
Azurity Pharmaceuticals, Inc.	2	$40
Sobi, Inc	2	$37
Genentech USA, Inc.	1	$35
Tersera Therapeutics LLC	1	$34
Deciphera Pharmaceuticals Inc.	1	$31
Geron Corporation	1	$30
Intercept Pharmaceuticals, Inc.	1	$30
Sun Pharmaceutical Industries Inc.	1	$27
Rigel Pharmaceuticals, Inc.	1	$26
Menarini Silicon Biosystems, Inc.	1	$22
Jazz Pharmaceuticals Inc.	1	$22
Legend Biotech USA Inc.	1	$22
Biocon Biologics Inc	1	$22
Iovance Biotherapeutics, Inc.	1	$21
Bard Peripheral Vascular, Inc.	1	$21
Astellas Pharma US Inc	1	$20
Adaptive Biotechnologies Corporation	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,222 in reported general payments places this provider in the 80th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$2,869,794

Medicare patients

430

Services billed

16,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	52	$608
Pilocarpine Hcl	29	$580
Mometasone Furoate	24	$383
Dexamethasone	30	$289
Lidocaine Hcl ViscousLidocaine Hcl	14	$220
Ondansetron OdtOndansetron	13	$219
SsdSilver Sulfadiazine	13	$183
Memantine Hcl	11	$168
Methylprednisolone	18	$119
Oxycodone Hcl	11	$108

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Gilbert

Michael SamuelsGilbert$323K
Terence RobertsGilbert$59K
Anna LikhachevaGilbert$8K
Chi ZhangScottsdale$495K
Michael GarciaSun City$366K
John KreslPhoenix$251K
Terence SioScottsdale$221K
Nitika ThawaniPhoenix$199K
Carlos VargasScottsdale$179K
Baldassarre SteaTucson$120K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →